Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis
Background. Growth arrest specific gene 6 (Gas6) protein enhances survival of oligodendrocytes and neurons, and it is involved in autoimmunity. Therefore, we aimed to verify whether cerebrospinal-fluid (CSF) Gas6 concentration may represent a biomarker of disease activity in multiple sclerosis. Meth...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2013/406483 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555437200769024 |
|---|---|
| author | P. P. Sainaghi L. Collimedaglia F. Alciato R. Molinari D. Sola E. Ranza P. Naldi F. Monaco M. Leone M. Pirisi G. C. Avanzi |
| author_facet | P. P. Sainaghi L. Collimedaglia F. Alciato R. Molinari D. Sola E. Ranza P. Naldi F. Monaco M. Leone M. Pirisi G. C. Avanzi |
| author_sort | P. P. Sainaghi |
| collection | DOAJ |
| description | Background. Growth arrest specific gene 6 (Gas6) protein enhances survival of oligodendrocytes and neurons, and it is involved in autoimmunity. Therefore, we aimed to verify whether cerebrospinal-fluid (CSF) Gas6 concentration may represent a biomarker of disease activity in multiple sclerosis. Methods. Sixty-five patients who underwent a spinal tap during relapse of relapsing/remitting multiple sclerosis (RR-MS)(McDonald-criteria) were studied. Forty patients affected by noninflammatory/nonautoimmune neurological diseases served as controls. Relapse was defined according to Schumacher criteria. Symptoms were grouped according to Kurtzke-Functional System (FS). Clinical characteristics of the relapse, duration, Expanded-Disability-Status Scale (EDSS) change, number of FS involved, completeness of recovery, age, steroid therapy, were categorised. Patients were followed at 6-month intervals to assess relapse rate and EDSS progression. Gas6 was measured (CSF, plasma) by in-house-enzyme-linked immunoassay (ELISA). Results. Higher CSF Gas6 concentrations were observed in relapses lasting ≤60 days (8.7 ± 3.9 ng/mL) versus >60 days (6.5 ± 2.6) or controls (6.5 ± 2.4; P=0.05), with ≤2 FS involved (8.5 ± 3.8) versus >2 FS (5.6 ± 2.5) (P<0.05) and EDSS change ≤2.5 points (8.8 ± 3.7) versus >2.5 (6.5 ± 3.5) (P=0.04). Conversely, CSF Gas6 was not predictive of the completeness of recovery. Plasma and CSF concentrations were not related (R2=0.0003), and neither were predictive of relapse rate or EDSS progression after first relapse. Conclusions. CSF concentration of Gas6 is inversely correlated with the severity of relapse in RR-MS patients but does not predict the subsequent course of the disease. |
| format | Article |
| id | doaj-art-e5e3537a226b4c67b396626df8553c91 |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-e5e3537a226b4c67b396626df8553c912025-02-03T05:48:17ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/406483406483Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple SclerosisP. P. Sainaghi0L. Collimedaglia1F. Alciato2R. Molinari3D. Sola4E. Ranza5P. Naldi6F. Monaco7M. Leone8M. Pirisi9G. C. Avanzi10AOU “Maggiore della Carità,” 28100 Novara, ItalyDepartment of Translational Medicine, “A. Avogadro” University, 28100 Novara, ItalyDepartment of Translational Medicine, “A. Avogadro” University, 28100 Novara, ItalyDepartment of Translational Medicine, “A. Avogadro” University, 28100 Novara, ItalyDepartment of Translational Medicine, “A. Avogadro” University, 28100 Novara, ItalyDepartment of Translational Medicine, “A. Avogadro” University, 28100 Novara, ItalyDepartment of Translational Medicine, “A. Avogadro” University, 28100 Novara, Italy(Interdisciplinary Research Center of Autoimmune Diseases) IRCAD, Via Solaroli 17, 28100 Novara, ItalyAOU “Maggiore della Carità,” 28100 Novara, Italy(Interdisciplinary Research Center of Autoimmune Diseases) IRCAD, Via Solaroli 17, 28100 Novara, Italy(Interdisciplinary Research Center of Autoimmune Diseases) IRCAD, Via Solaroli 17, 28100 Novara, ItalyBackground. Growth arrest specific gene 6 (Gas6) protein enhances survival of oligodendrocytes and neurons, and it is involved in autoimmunity. Therefore, we aimed to verify whether cerebrospinal-fluid (CSF) Gas6 concentration may represent a biomarker of disease activity in multiple sclerosis. Methods. Sixty-five patients who underwent a spinal tap during relapse of relapsing/remitting multiple sclerosis (RR-MS)(McDonald-criteria) were studied. Forty patients affected by noninflammatory/nonautoimmune neurological diseases served as controls. Relapse was defined according to Schumacher criteria. Symptoms were grouped according to Kurtzke-Functional System (FS). Clinical characteristics of the relapse, duration, Expanded-Disability-Status Scale (EDSS) change, number of FS involved, completeness of recovery, age, steroid therapy, were categorised. Patients were followed at 6-month intervals to assess relapse rate and EDSS progression. Gas6 was measured (CSF, plasma) by in-house-enzyme-linked immunoassay (ELISA). Results. Higher CSF Gas6 concentrations were observed in relapses lasting ≤60 days (8.7 ± 3.9 ng/mL) versus >60 days (6.5 ± 2.6) or controls (6.5 ± 2.4; P=0.05), with ≤2 FS involved (8.5 ± 3.8) versus >2 FS (5.6 ± 2.5) (P<0.05) and EDSS change ≤2.5 points (8.8 ± 3.7) versus >2.5 (6.5 ± 3.5) (P=0.04). Conversely, CSF Gas6 was not predictive of the completeness of recovery. Plasma and CSF concentrations were not related (R2=0.0003), and neither were predictive of relapse rate or EDSS progression after first relapse. Conclusions. CSF concentration of Gas6 is inversely correlated with the severity of relapse in RR-MS patients but does not predict the subsequent course of the disease.http://dx.doi.org/10.1155/2013/406483 |
| spellingShingle | P. P. Sainaghi L. Collimedaglia F. Alciato R. Molinari D. Sola E. Ranza P. Naldi F. Monaco M. Leone M. Pirisi G. C. Avanzi Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis Mediators of Inflammation |
| title | Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis |
| title_full | Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis |
| title_fullStr | Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis |
| title_full_unstemmed | Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis |
| title_short | Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis |
| title_sort | growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis |
| url | http://dx.doi.org/10.1155/2013/406483 |
| work_keys_str_mv | AT ppsainaghi growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT lcollimedaglia growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT falciato growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT rmolinari growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT dsola growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT eranza growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT pnaldi growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT fmonaco growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT mleone growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT mpirisi growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis AT gcavanzi growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis |